Rhythm Pharmaceuticals, Inc. (BMV:RYTM)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,866.76
-158.24 (-7.81%)
At close: Nov 18, 2025

Rhythm Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-196.54-260.6-184.68-181.12-69.61
Upgrade
Depreciation & Amortization
1.341.561.761.671.16
Upgrade
Loss (Gain) From Sale of Investments
-6.52-8.17-9.84-1.27-
Upgrade
Stock-Based Compensation
66.8239.6832.5519.8320.8
Upgrade
Other Operating Activities
20.19103.0719.244.87-100.25
Upgrade
Change in Accounts Receivable
-7.57-3.65-8.64-5.2-1.25
Upgrade
Change in Inventory
-7.47-10.12-5.71-2.81-0.01
Upgrade
Change in Accounts Payable
21.8921.9214.771.5418.31
Upgrade
Change in Unearned Revenue
-1.09--0.15-6.61-
Upgrade
Change in Other Net Operating Assets
-6.722.424.53-4.34-15.15
Upgrade
Operating Cash Flow
-115.68-113.88-136.16-173.43-146
Upgrade
Capital Expenditures
-0.95--0.05-0.28-0.43
Upgrade
Sale (Purchase) of Intangibles
-40-40.5-5.67-7
Upgrade
Investment in Securities
-96.2-7.670.0532.31-163.73
Upgrade
Other Investing Activities
----495
Upgrade
Investing Cash Flow
-137.15-48.17-5.6728.03-62.16
Upgrade
Issuance of Common Stock
237.8856.3957.4141.49166.48
Upgrade
Other Financing Activities
-19.92-416.9772.34-
Upgrade
Financing Cash Flow
217.96191.2474.37213.83166.48
Upgrade
Foreign Exchange Rate Adjustments
0.090-0.14--
Upgrade
Net Cash Flow
-34.7829.19-67.668.43-41.68
Upgrade
Free Cash Flow
-116.63-113.88-136.2-173.71-146.44
Upgrade
Free Cash Flow Margin
-61.46%-87.51%-175.91%-734.87%-4642.90%
Upgrade
Free Cash Flow Per Share
-1.79-1.87-2.36-3.33-2.95
Upgrade
Levered Free Cash Flow
-145.98-81.99-91.47-105.11-57.05
Upgrade
Unlevered Free Cash Flow
-133.12-69.11-82.79-101.86-57.05
Upgrade
Change in Working Capital
-0.9710.584.81-17.411.9
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.